BioPharmSignal logoBioPharmSignal

Biotech News

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro (CLPT)ClearPoint NeuroFDA / regulatory

CLPT (CLPT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is clpt.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

CLPTClearPoint Neuro2026-07-31 20:05 EST

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel

HYPRHyperfine2026-08-20 12:15 EST

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

SGHTSight Sciences2026-08-04 21:38 EST

Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

ICCMIceCure Medical2026-07-06 12:11 EST

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer

ICCMIceCure Medical2026-07-29 12:25 EST

IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®

CLPTClearPoint Neuro2026-08-03 20:05 EST

ClearPoint Neuro Reports Second Quarter 2026 Results

ADPTAdaptive Biotechnologies2026-06-30 12:30 EST

Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial

AORTArtivion2026-06-29 11:00 EST

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

FEMYFEMASYS2026-08-19 13:00 EST

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®

ANGOAngioDynamics2026-06-17 12:30 EST

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)

View all latest news

ClearPoint Neuro

Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine. ClearPoint Navigation The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics. Cell...

Recent company news

CLPTClearPoint Neuro2026-08-03 20:05 EST

ClearPoint Neuro Reports Second Quarter 2026 Results

CLPTClearPoint Neuro2026-07-31 20:05 EST

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel

CLPTClearPoint Neuro2026-07-21 20:05 EST

ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026

CLPTClearPoint Neuro2026-05-27 20:30 EST

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

CLPTClearPoint Neuro2026-05-13 20:05 EST

ClearPoint Neuro Reports First Quarter 2026 Results

Stock data

Close
15.39 USD
Market cap
370.97M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States